Etiket: BioNTech
Outlook: BioNTech reports figures for the latest quarter
shares in this article BioNTech (ADRs) will open the books for the past quarter ended 6/30/2022 at its quarter-end financial conference on 8/8/2022. The estimates of 10 analysts assume an…
BioNTech, Novavax, Moderna shares and Co. in focus: So much vaccine has already been delivered to Germany
shares in this article Moderna and BioNTech/Pfizer supplied the most vaccines in Europe and the US The global vaccination campaign caused a rain of money for the manufacturers – and…
BioNTech and Pfizer investigate new vaccine candidate: should also be effective against omikron
German pharmaceutical company BioNTech and its American partner Pfizer have launched a new study into the efficacy and safety of a vaccine candidate. The possible vaccine would work according to…
Novavax, Moderna, BioNTech, CureVac & Co: Pandemic doesn’t take a break – waiting for autumn
shares in this article by Julia Groß, €uro on Sunday WWhilst the stream of visitors in the remaining German vaccination centers is rather sparse, a booking website for the…
BioNTech Stock, Pfizer Stock and Moderna Stock: New Data on Omicron Vaccines
shares in this article For example, Pfizer/BioNTech and Moderna recently published results according to which their adapted boosters also stimulate an efficient immune response against the newer omicron sublines BA.4…
BioNTech, Pfizer & Moderna: US Food and Drug Administration Recommendation for Corona Vaccination for Young Children
shares in this article Both the vaccine from the manufacturers BioNTech and Pfizer and the preparation from Moderna could be used for around 18 million small children, the experts decided…
Moderna, BioNTech & Pfizer stocks at odds: EMA reviews Moderna’s Omicron vaccine – Corona vaccines get emergency use approval for small children in USA
shares in this article The US Food and Drug Administration (FDA) has given them emergency use approvals for this age group, the manufacturers said on Friday. Previously, after hours of…
BioNTech, Pfizer and Moderna stocks still under pressure: FDA approves corona vaccines for smaller children
shares in this article Both the vaccine from the manufacturers BioNTech and Pfizer and the preparation from Moderna could be used for this, the committee unanimously decided on Wednesday after…
DAX under heavy pressure, Fed aftermath, CHFUSD, BioNTech and Netflix in the analysis
shares in this article indexes in this article In some federal states, the DAX is no longer able to hold up as well as it did on Wednesday and is…
BioNTech shares, Pfizer shares & Co.: Boosters for the courses
shares in this article by Julia Groß, Euro am Sonntag BioNTech and Pfizer have received approval in the USA for booster shots, i.e. the third vaccination for five to eleven…